These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 27580354

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Expression profiles of cadherin 17 and claudin 18.2 in comparison with peptide hormonal expression in pancreatic neuroendocrine tumours: Implications for targeted immunotherapy.
    Maeda K, Uehara T, Hosoda W, Kuraishi Y, Ota H.
    Pathol Res Pract; 2024 Oct; 262():155537. PubMed ID: 39178509
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer.
    Jin EH, Lee DH, Jung SA, Shim KN, Seo JY, Kim N, Shin CM, Yoon H, Jung HC.
    World J Gastroenterol; 2015 Jan 14; 21(2):571-7. PubMed ID: 25593477
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. HER2 expression variability between primary gastric cancers and corresponding lymph node metastases.
    Qiu Z, Sun W, Zhou C, Zhang J.
    Hepatogastroenterology; 2015 Jan 14; 62(137):231-3. PubMed ID: 25911901
    [Abstract] [Full Text] [Related]

  • 8. Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases.
    Coati I, Lotz G, Fanelli GN, Brignola S, Lanza C, Cappellesso R, Pellino A, Pucciarelli S, Spolverato G, Guzzardo V, Munari G, Zaninotto G, Scarpa M, Mastracci L, Farinati F, Realdon S, Pilati P, Lonardi S, Valeri N, Rugge M, Kiss A, Loupakis F, Fassan M.
    Br J Cancer; 2019 Jul 14; 121(3):257-263. PubMed ID: 31235864
    [Abstract] [Full Text] [Related]

  • 9. The distinct expression patterns of claudin-10, -14, -17 and E-cadherin between adjacent non-neoplastic tissues and gastric cancer tissues.
    Gao M, Li W, Wang H, Wang G.
    Diagn Pathol; 2013 Dec 10; 8():205. PubMed ID: 24325792
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunophenotype analysis using CLDN18, CDH17, and PAX8 for the subcategorization of endocervical adenocarcinomas in situ: gastric-type, intestinal-type, gastrointestinal-type, and Müllerian-type.
    Asaka S, Nakajima T, Kugo K, Kashiwagi R, Yazaki N, Miyamoto T, Uehara T, Ota H.
    Virchows Arch; 2020 Apr 10; 476(4):499-510. PubMed ID: 31932920
    [Abstract] [Full Text] [Related]

  • 13. A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma.
    Ge J, Chen Z, Wu S, Yuan W, Hu B, Chen Z.
    Clin Oncol (R Coll Radiol); 2008 May 10; 20(4):275-83. PubMed ID: 18353622
    [Abstract] [Full Text] [Related]

  • 14. The clinical usefulness of the intraoperative detection of sentinel lymph node metastases by a rapid RT-PCR system in patients with gastric cancer.
    Yanagita S, Uenosono Y, Arigami T, Daisuke M, Okubo K, Kijima T, Arima H, Hirata M, Haraguchi N, Hagihara T, Nishizono Y, Ishigami S, Natsugoe S.
    Cancer; 2016 Feb 01; 122(3):386-92. PubMed ID: 26479552
    [Abstract] [Full Text] [Related]

  • 15. Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer.
    Ito R, Oue N, Yoshida K, Kunimitsu K, Nakayama H, Nakachi K, Yasui W.
    Virchows Arch; 2005 Oct 01; 447(4):717-22. PubMed ID: 16044349
    [Abstract] [Full Text] [Related]

  • 16. Analysis of the expression and genetic alteration of CLDN18 in gastric cancer.
    Li J, Zhang Y, Hu D, Gong T, Xu R, Gao J.
    Aging (Albany NY); 2020 Jul 15; 12(14):14271-14284. PubMed ID: 32668412
    [Abstract] [Full Text] [Related]

  • 17. 111In-labeled anti-cadherin17 antibody D2101 has potential as a noninvasive imaging probe for diagnosing gastric cancer and lymph-node metastasis.
    Fujiwara K, Tsuji AB, Sudo H, Sugyo A, Akiba H, Iwanari H, Kusano-Arai O, Tsumoto K, Momose T, Hamakubo T, Higashi T.
    Ann Nucl Med; 2020 Jan 15; 34(1):13-23. PubMed ID: 31605356
    [Abstract] [Full Text] [Related]

  • 18. Plasma expression of the intestinal metaplasia markers CDH17 and TFF3 in patients with gastric cancer.
    Choi B, Lee HJ, Min J, Choe HN, Choi YS, Son YG, Ahn HS, Suh YS, Goldenring JR, Yang HK.
    Cancer Biomark; 2017 Jul 04; 19(3):231-239. PubMed ID: 28453457
    [Abstract] [Full Text] [Related]

  • 19. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y, Inokuchi M, Takagi Y, Otsuki S, Fujimori Y, Yanaka Y, Kobayashi K, Higuchi K, Kojima K, Kawano T.
    J Clin Pathol; 2015 Oct 04; 68(10):795-801. PubMed ID: 26043748
    [Abstract] [Full Text] [Related]

  • 20. Spatial expression of claudin 18.2 in matched primaries and metastases of tubo-ovarian carcinoma of all subtypes.
    Wagner P, Gass P, Pöschke P, Eckstein M, Gloßner L, Hartmann A, Beckmann MW, Fasching PA, Ruebner M, Emons J, Erber R.
    Virchows Arch; 2024 Jul 04; 485(1):63-74. PubMed ID: 38326579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.